Finance

Lists
002727:SHE
Yixintang Pharmaceutical Co Ltd
12,98 CNY
+1,49%
(+0,19) 1D
16 ოქტ, 15:04:18 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002727...
Open
12,76 CNY
High
13,10 CNY
Low
12,56 CNY
Mkt. cap
7,49 მლრდ.
Avg. vol.
7,18 მლნ.
Volume
32,50 მლნ.
Dividend
3,08%
Quarterly dividend
0,10 CNY
Ex-dividend date
24 სექ. 2026
P/E ratio
27,78
52-wk high
14,80 CNY
52-wk low
9,41 CNY
EPS
0,47 CNY
Shares outstanding
585,60 მლნ.
No. of employees
35 ათ.
Open
12,76 CNY
High
13,10 CNY
Low
12,56 CNY
Mkt. cap
7,49 მლრდ.
Avg. vol.
7,18 მლნ.
Volume
32,50 მლნ.
Dividend
3,08%
Quarterly dividend
0,10 CNY
Ex-dividend date
24 სექ. 2026
P/E ratio
27,78
52-wk high
14,80 CNY
52-wk low
9,41 CNY
EPS
0,47 CNY
Shares outstanding
585,60 მლნ.
No. of employees
35 ათ.
News stories
From web sources and news partners
About Yixintang Pharmaceutical Co Ltd
CEO-
Employees34,8 ათ.
Founded8 ნოე. 2000
Headquarters-
SectorDrug
Websitehx8886.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
4,09 მლრდ.
4,34 მლრდ.
4,43 მლრდ.
4,03 მლრდ.
Cost of goods sold
2,70 მლრდ.
3,05 მლრდ.
2,97 მლრდ.
2,74 მლრდ.
Cost of revenue
2,70 მლრდ.
3,05 მლრდ.
2,97 მლრდ.
2,74 მლრდ.
Research and development expenses
1,30 მლნ.
1,57 მლნ.
797,19 ათ.
2,03 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,21 მლრდ.
1,25 მლრდ.
1,20 მლრდ.
1,21 მლრდ.
Operating expense
1,21 მლრდ.
1,30 მლრდ.
1,19 მლრდ.
1,21 მლრდ.
Total operating expenses
3,91 მლრდ.
4,35 მლრდ.
4,15 მლრდ.
3,95 მლრდ.
Operating income
174,68 მლნ.
-14,76 მლნ.
281,17 მლნ.
85,87 მლნ.
Other non operating income
-10,37 მლნ.
7,40 მლნ.
-543,11 ათ.
36,43 ათ.
EBT including unusual items
40,85 მლნ.
43,99 მლნ.
225,14 მლნ.
121,49 მლნ.
EBT excluding unusual items
135,97 მლნ.
-37,76 მლნ.
255,65 მლნ.
65,14 მლნ.
Income tax expense
19,51 მლნ.
52,23 მლნ.
47,31 მლნ.
37,59 მლნ.
Effective tax rate
47,75%
118,75%
21,01%
30,94%
Other operating expenses
-26,48 მლნ.
23,96 მლნ.
-16,25 მლნ.
7,62 მლნ.
Net income
18,94 მლნ.
-5,16 მლნ.
175,81 მლნ.
81,04 მლნ.
Net profit margin
0,46%
-0,12%
3,97%
2,01%
Earnings per share
0,01
-0,01
0,28
0,12
Interest and investment income
4,32 მლნ.
3,69 მლნ.
3,93 მლნ.
5,46 მლნ.
Interest expense
-32,65 მლნ.
-34,10 მლნ.
-28,91 მლნ.
-26,23 მლნ.
Net interest expenses
-28,34 მლნ.
-30,40 მლნ.
-24,98 მლნ.
-20,77 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
202,06 მლნ.
12,28 მლნ.
308,21 მლნ.
111,56 მლნ.
Gain or loss from assets sale
1,41 მლნ.
-8,79 მლნ.
-
-3,12 მლნ.
AI content may include mistakes. Learn more
Google აპები